Metabolic Myopathies and HyperCKemia in Adulthood: A Clinical Approach to Diagnosis and Management
Journal of Clinical Medicine · 09.03.2026 · 15 (5) · 2070
DOI: 10.3390/jcm15052070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.03.2026. Verfasst von Loai A Shakerdi. Beteiligte Einrichtung: School of Public Health, University College Dublin, D04 V1W8 Dublin, Ireland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
HyperCKemia, defined as elevated serum creatine kinase, commonly reflects muscle injury but may also indicate underlying metabolic disease. Metabolic aetiologies, including glycogen storage disorders, fatty acid oxidation defects, mitochondrial cytopathies, and purine metabolism disorders, are clinically important owing to diagnostic complexity, therapeutic implications, and potential reversibility.
Objective
To summarise current evidence on metabolic causes of hyperCKemia in adults, with emphasis on disorders of carbohydrate, lipid, and purine metabolism and mitochondrial disease.
Methods
Semi-systematic narrative review of pathophysiology, clinical features, diagnostic approaches, and management of metabolic disorders associated with hyperCKemia.
Results
Metabolic myopathies often present with nonspecific or exercise-related symptoms, with creatine kinase levels ranging from mild-to-severe elevations. Conditions such as McArdle disease, carnitine palmitoyltransferase II deficiency, and mitochondrial cytopathies demonstrate characteristic metabolic vulnerabilities leading to episodic or persistent hyperCKemia. Medications, including statins and antiretrovirals, may precipitate symptoms in predisposed individuals. Diagnosis requires a structured, multidisciplinary approach incorporating biochemical testing, genetic analysis, functional studies, and muscle biopsy. Many causes are amenable to targeted therapy, including dietary modification, endocrine correction, and medication withdrawal.
Conclusion
Metabolic causes of hyperCKemia are under-recognised but clinically significant. Early identification allows targeted treatment and prevention of complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health, University College Dublin, D04 V1W8 Dublin, Ireland.
- National Centre for Inherited Metabolic Disorders, Mater Misericordiae University Hospital, Eccles St, Phibsborough, D07 R2WY Dublin, Ireland.
ORCID-Profile: Loai A Shakerdi
Zitieren
APA
Shakerdi, L. A. (2026). Metabolic Myopathies and HyperCKemia in Adulthood: A Clinical Approach to Diagnosis and Management. Journal of Clinical Medicine, 15(5), 2070. https://doi.org/10.3390/jcm15052070
Vancouver
Shakerdi LA. Metabolic Myopathies and HyperCKemia in Adulthood: A Clinical Approach to Diagnosis and Management. Journal of Clinical Medicine. 2026;15(5):2070. doi:10.3390/jcm15052070
BibTeX
@article{Shakerdi2026,
author = {Shakerdi, Loai A},
title = {Metabolic Myopathies and HyperCKemia in Adulthood: A Clinical Approach to Diagnosis and Management},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {5},
pages = {2070},
doi = {10.3390/jcm15052070}
}
EUVIMED